New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2013
12:42 EDTPMTI, CYNOCynosure acquisition positive, says Maxim
After Cynosure (CYNO) agreed to buy Palomar Medical (PMTI), Maxim thinks the deal will be positive over time for Cynosure, as it believes the deal should increase the company's revenue growth. The firm, however, warns that Cynosure's stock could drop in the short-term. Maxim maintains a Buy rating on Cynosure.
News For CYNO;PMTI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
07:27 EDTCYNOCynosure new product potential not fully appreciated, says Brean Capital
Subscribe for More Information
June 25, 2015
09:24 EDTCYNOCynosure price target raised to $46 from $42 at Northland
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use